Physician

Levent Akduman, MD

According to 2025 Medicare claims, Levent Akduman, MD (NPI: 1245344605) practices ophthalmology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from Madison, IL. This provider's primary affiliated billing organization is JFJ EYECARE, LTD (NPI: 1376586685; TIN: 371099270) and primary practice location at 62226-1919. Akduman is affiliated with the IRCCO (ACO ID: A2619) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Akduman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,278 traditional Medicare patients, billed 30,306 HCPCS/CPT codes, and received $3,211,569 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,297 prescription claims across 481 beneficiaries totaling $82,963 in drug costs, led by Tobramycin-Dexamethasone (Tobramycin/Dexamethasone). Open Payments data shows 47 records totaling $13,768. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $396,688 to $3,211,569. Similarly, Part D prescription costs have risen steadily, from $4,917 to $82,963. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	578	4,225	$396,688
2016	536	3,889	$357,477
2017	1,185	7,694	$1,248,343
2018	1,488	17,713	$3,819,563
2019	1,971	18,207	$3,583,602
2020	1,719	16,241	$3,081,347
2021	1,742	15,750	$2,906,991
2022	1,613	16,389	$2,577,448
2023	1,518	36,480	$3,214,232
2024	1,278	30,306	$3,211,569

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	22	58	$4,917
2016	18	40	$4,587
2017	113	236	$18,862
2018	362	995	$93,104
2019	462	1,350	$132,441
2020	428	1,284	$140,988
2021	478	1,470	$153,812
2022	467	1,485	$171,519
2023	500	1,375	$141,949
2024	481	1,297	$82,963

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	246	2,632	$656
67028	Injection of drug into eye	562	2,294	$87
92014	Established patient complete exam of visual system	667	827	$83
92134	Imaging of retina	601	1,678	$27
92250	Photography of the retina	938	1,389	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	343	8,811	$15,098
Lumigan	Bimatoprost	19	1,000	$6,678
Prednisolone Acetate	Prednisolone Acetate	152	7,884	$6,547
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	23	1,615	$3,826
Brimonidine Tartrate	Brimonidine Tartrate	90	4,961	$3,739

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$13,768	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Levent Akduman, MD?

Tedicare shows public-source Medicare data for Levent Akduman, MD (NPI 1245344605), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Levent Akduman, MD have ACO affiliation data?

Levent Akduman, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Levent Akduman, MD?

Levent Akduman, MD is linked to JFJ EYECARE, LTD (billing NPI 1376586685) in the available physician profile data.

Does Levent Akduman, MD have Open Payments data?

Levent Akduman, MD has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.